Does Your Ingredient Still Qualify as a “Dietary Fiber” in the United States?

If you want to understand FDA’s current position on dietary fiber and key considerations regarding processes (i.e., citizen petitions) and evidence requirements for substantiating the health effects of dietary fibers, then don’t miss out on this important webinar!

In May of this year, the U.S. FDA released a definition for “dietary fiber”, which defines the types of dietary fiber that can contribute to the “dietary fiber” declaration in Nutrition and Supplement Facts labels. For ingredients that are “isolated or synthetic non-digestible carbohydrates”, the FDA must first approve the ingredient’s beneficial physiological effect via an assessment of the totality of pertinent scientific evidence. If the scientific evidence substantiates the ingredient’s beneficial effect in humans, the regulatory definition of dietary fiber will be amended to include the name of the dietary fiber in the list of fibers appearing in the definition. The challenge: Effects currently considered by the FDA as “beneficial” are very specific and notably do not include fermentation or changes in the microbiota – effects traditionally associated with prebiotics.

Topics covered include:

  • Overview of FDA’s new definition of dietary fiber and its impact on industry
  • FDA’s evidence requirements for demonstrating a fiber’s beneficial physiological effect
  • Overview of the requirements of a citizen petition

Who should download?
Ingredient, food, or dietary supplement manufacturers or associations involved in research and development, scientific affairs, regulatory affairs, marketing/advertising.

Please complete the form below to view the webinar recording.